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Background
Acute myocardial infarction remains a major cause of
morbidity and mortality worldwide. As such, there is a
need for improved cardioprotective strategies. Nitrite
represents an alternative source of bioactive nitric oxide
(NO) particularly during hypoxia [1], and recent studies
have demonstrated that nitrite is protective against myo-
cardial ischemia reperfusion (I/R) injury [2]. Several
mechanisms of nitrite bioconversion to NO have been
proposed, such as xanthine oxidase [3], deoxyhaemoglobin
and myoglobin [4], but the cytoprotective effects of nitrite
therapy remains to be elucidated. Recent experimental
data have shown that mice deficient in endothelial nitric
oxide synthase (eNOS) exhibit reduced steady state levels
of both plasma and cardiac nitrite levels when compared
to the wild-type mice. Thus suggesting that nitrite restores
NO bioavailability [5]. Herein, we have investigated
whether these effects are translated in man and therefore
assessed the effects of nitrite therapy on eNOS phos-
phorylation and expression in human left ventricle (LV)
biopsies.
Materials and methods
Patients elected for coronary artery bypass grafting
(CABG) surgery were subjected to either placebo (saline)
or nitrite treatment 10 mcg/kg/min either 30 minutes or
24 hours before surgery. Full thickness LV myocardial
free wall tru-cut biopsies were obtained from adjacent
non-fibrotic regions just prior to aortic clamping (pre-
ischemia) and at 10 minutes post-reperfusion. Biopsies
were snap frozen in liquid N2 within 1 minute of collec-
tion. To determine the effects of nitrite on eNOS
expression and phosphorylation status at residue
ser1177, Western blot analyses were performed.
Results
In pre-ischemia LV biopsies, 10 mcg/kg/min nitrite
administration 24 hours or 30 minutes before CABG sur-
gery caused a significant increase in eNOS phosphoryla-
tion at ser1177 when compared to the placebo group.
A similar trend was observed for the expression of total
eNOS. LV biopsies taken at reperfusion also demonstrated
a significant increase in both total eNOS expression and
eNOS phosphorylation at ser1177.
Conclusion
Nitrite upregulates phosphorylation of eNOS at residue
s1177 in patients undergoing CABG surgery. Furthermore,
total eNOS expression is also increased in these patients,
thus suggesting that nitrite may mediate cardioprotection
through eNOS signalling pathway and may potentially
restore NO bioavailability.
Acknowledgements
This project was funded by the Medical Research Council.
Authors’ details
1Centre for Cardiovascular Sciences, College of Medical and Dental Sciences,
School of Clinical and Experimental Medicine, University of Birmingham, B15
2TT, UK. 2Queen Elizabeth Hospital Birmingham, University of Birmingham,
Birmingham, UK. 3University of Aberdeen, Aberdeen, UK.
Published: 29 August 2013
References
1. Lundberg JO, Weitzberg E, Gladwin MT: The nitrate-nitrite-nitric oxide
pathway in physiology and therapeutics. Nat Rev Drug Discov 2008,
7:156-167.
2. Baker JE, Su J, Fu X, Hsu A, Gross GJ, Tweddell JS, Hogg N: Nitrite confers
protection against myocardial infarction: role of xanthine
oxidoreductase, NADPH oxidase and K(ATP) channels. J Mol Cell Cardiol
2007, 43:437-444.
* Correspondence: m.madhani@bham.ac.uk
1Centre for Cardiovascular Sciences, College of Medical and Dental Sciences,
School of Clinical and Experimental Medicine, University of Birmingham, B15
2TT, UK
Full list of author information is available at the end of the article
Bailey et al. BMC Pharmacology and Toxicology 2013, 14(Suppl 1):P3
http://www.biomedcentral.com/2050-6511/14/S1/P3
© 2013 Bailey et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons
Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in
any medium, provided the original work is properly cited.
3. Li H, Cui H, Kundu TK, Alzawahra W, Zweier JL: Nitric oxide production
from nitrite occurs primarily in tissues not in the blood: critical role of
xanthine oxidase and aldehyde oxidase. J Biol Chem 2008,
283:17855-17863.
4. Shiva S, Huang Z, Grubina R, Sun J, Ringwood LA, MacArthur PH, Xu X,
Murphy E, Darley-Usmar VM, Gladwin MT: Deoxymyoglobin is a nitrite
reductase that generates nitric oxide and regulates mitochondrial
respiration. Cir Res 2007, 100:654-661.
5. Bryan NS, Clavert HW, Gundewar S, Lefer DJ: Dietary nitrite restores NO
homeostasis and is cardioprotective in eNOS deficient mice. Free Radical
Biol Med 2008, 45:468-474.
doi:10.1186/2050-6511-14-S1-P3
Cite this article as: Bailey et al.: Effect of nitrite treatment on endothelial
nitric oxide synthase in human left ventricle biopsy. BMC Pharmacology
and Toxicology 2013 14(Suppl 1):P3.
Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color figure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
Bailey et al. BMC Pharmacology and Toxicology 2013, 14(Suppl 1):P3
http://www.biomedcentral.com/2050-6511/14/S1/P3
Page 2 of 2
